1-4 of 4
Bin Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study

Clinical Trials & Observations
Li-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, Ming-Zhi Zhang, Zhi-Ming Li, Chun-Yan Ji, Wei Xu, Ting Liu, Bing Xu, Xin Wang, Su-Jun Gao, Hui-Lai Zhang, Yu Hu, Yan Li, Ying Cheng, Hai-Yan Yang, Jun-Ning Cao, Zun-Min Zhu, Jian-Da Hu, Wei Zhang, Hong-Mei Jing, Kai-Yang Ding, Xiang-Yang Zhang, Ren-Bin Zhao, Bin Zhang, Ya-Min Tian, Yong-Ping Song, Yu-Qin Song, Jun Zhu
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4349–4357.
https://doi.org/10.1182/bloodadvances.2022009168
Published: 2023
Includes: Supplemental data
Journal Articles

Separate roles of LMAN1 and MCFD2 in ER-to-Golgi trafficking of FV and FVIII

Yuan Zhang, Zhigang Liu, Bin Zhang
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1286–1296.
https://doi.org/10.1182/bloodadvances.2022008788
Published: 2023
Includes: Supplemental data
Journal Articles

Altered phenotype in LMAN1-deficient mice with low levels of residual LMAN1 expression

Lesley A. Everett, Rami N. Khoriaty, Bin Zhang, David Ginsburg
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5635–5643.
https://doi.org/10.1182/bloodadvances.2020002523
Published: 2020
Includes: Supplemental data
Journal Articles

Analysis of MCFD2- and LMAN1-deficient mice demonstrates distinct functions in vivo

Min Zhu, Chunlei Zheng, Wei Wei, Lesley Everett, David Ginsburg, Bin Zhang
Journal: Blood Advances
Blood Adv (2018) 2 (9): 1014–1021.
https://doi.org/10.1182/bloodadvances.2018018317
Published: 2018